185750.KS KSC
Chong Kun Dang Pharmaceutical Corp.
1W: +0.5%
1M: -5.2%
3M: -3.7%
YTD: -30.2%
1Y: -21.2%
3Y: -6.3%
5Y: -40.3%
₩65,200.00 ($48.56)
+0.00 (+0.00%)
Weekly Expected Move ±2.3%
₩62184
₩63692
₩65200
₩66708
₩68216
Overview
Chart
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ETF Exposure
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap₩859.1B ($639.9M)
52W Range63000-106800
Volume11,872
Avg Volume28,174
Beta-0.43
Dividend₩500.00
Analyst Ratings
No analyst coverage
Company Info
CEOYoung-Ju Kim
Employees2,304
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2013-12-06
Websiteckdpharm.com
Chong Kun Dang Building
Seoul, SL 03742
KR
Seoul, SL 03742
KR
82 2 2194 0300
About Chong Kun Dang Pharmaceutical Corp.
Chong Kun Dang Pharmaceutical Corp. engages in the manufacture, distribution, research, and development of pharmaceuticals. Its products include medicine for antidiabetics, antiviruses, beta-blockers, anti-hyperlipidemia, and others. The company was founded on May 7, 1941 and is headquartered in Seoul, South Korea.
Latest News
No recent news
Recent Insider Trades
No insider trades found